Being familiar with the consequences of psychedelics on human brain networks is crucial to unlocking their therapeutic mechanisms. In humans, in the around 6?hour period of action, psilocybin raises glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the power of electrophysiological signals22, reduces hemodynamic fluctuation